This document provides an introduction to blood transfusion. It begins with definitions of key terms like blood bank and blood donor. It then provides a brief history of blood banking, noting important developments like the use of anticoagulants and refrigerated storage. The document outlines the collection and processing of whole blood into components like red blood cells, plasma, platelets and cryoprecipitate. It discusses the storage and management of these blood products, including shelf lives and temperatures. It also defines red blood cell storage lesion and discusses efforts to minimize its effects. In summary, the document introduces students
how to select a healthy donor & care of donor .A healthy donor is one of the most vital part of transfusion medicine for safe transfusion of blood & blood product
how to select a healthy donor & care of donor .A healthy donor is one of the most vital part of transfusion medicine for safe transfusion of blood & blood product
blood and blood component have an important role in transfusion medicine. when blood contain all its part and no separation is done thats known as whole blood but when you centrifuge and separate it that is know as component. transfusion of whole blood is now adays absolute from transfusion service and blood components are transfuses now a days which is a good practice and beneficial for the patient
blood and blood component have an important role in transfusion medicine. when blood contain all its part and no separation is done thats known as whole blood but when you centrifuge and separate it that is know as component. transfusion of whole blood is now adays absolute from transfusion service and blood components are transfuses now a days which is a good practice and beneficial for the patient
Intended Learning Outcomes:
Describe the physiology of human fluid dynamics.
Define Intravenous therapy.
List the aims of adult perioperative fluid therapy.
Recognize the commonly used fluid preparations.
Describe the properties and indications of widely used IV solutions.
Describe the side effects and precautions of widely used IV solutions.
Explain the (NICE) principles and protocols for intravenous fluid therapy.
Discuss the assessment and management of hydration and volume status of surgical patients.
Describe the type, rate, and volume of fluid administered to surgical patients.
Recognize the different types of venous access.
Explain the potential local complications of peripheral IV therapy.
Identify the universal equations used by nurses to calculate the IV flow rate and medication dosage.
Preserved blood cells undergo progressive functional and structural changes that reduce oxygen delivery to tissues
The release of extracellular vesicles and cell-free DNA during storage may cause a hypercoagulable state
STORAGE LESION : amalgamation of reversible and irreversible changes that begin after 2 to 3 weeks of storage, progress with duration of storage and reduce red-cell function and viability after transfusion
Storage of Blood Components- equipments, effects of improper storage, transpo...DrShinyKajal
Introduction
Equipments required
Harmful effects of improper storage
Storage of various blood components- AABB guidelines
NACO guidelines for storage
Storage during transport
Storage in frozen state
Physical and chemical changes in stored blood
Lecture notes about the general examination of urine (Physical, chemical, and microscopic exam) for the first-year Medical Lab Technology Students.
Technical Institute of Baqubah, Middle Technical University, Baqubah, Iraq
Lecture notes about blood cell count (RBCs, WBCs, PLTs, as well as DLC)
For first-level students, Medical Lab Technology Dept. (Middle Technical University)
Erythrocyte Sedimentation Rate (ESR), a lecture for medical lab technicians at Baquba Technical Institute, Middle Technical University. All theoretical and practical notes about the test.
Notes about blood hemoglobin estimation, lecture notes to Medical Laboratory Students at Medical Laboratory Technology, Middle Technical University, Baqubah, Iraq
All about blood collection and handling, lecture notes to Medical Laboratory Students at Medical Laboratory Technology, Middle Technical University, Baqubah, Iraq
الفحص المختبري وتفسير النتائج لالتهاب الكبد الفايروسي BHussein Al-tameemi
محاضرة هامة ومبسطة في تشخيص التهاب الكبد الفايروسي نوع ب مختبريا، والتي ينبغي أن تكون محل اهتمام فنيي المختبرات ومصارف الدم العراقية والاطباء والناس عامة.
A lecture for first-year students at Baquba Technical Institute belongs to Middle Technical University. This lecture is a part of the first semester's modules (Medical Laboratory Technology: MLT112).
This lecture included an introduction to medical (or diagnostic) laboratories.
A brief presentation for second-year students in Iraqi Technical Institutes (studying Medical Laboratory Technology). This introduction covers the types of blood samples, how to collect these samples, common sites for collection, and anticoagulants in a test-tubes.
A brief presentation for second-year students in Iraqi Technical Institutes (studying Medical Laboratory Technology). This introduction covers also the teaching laboratories.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
1. INTRODUCTION TO BLOOD
TRANSFUSION
Hussein A. Abid
B. Sc. M. Clin. L. T. (ASMM, ASBMBM)
Middle Technical University
Ba’aquba Medical Technical Institute
Medical Laboratory Technology Department
Blood Transfusion Course
Lecture: 1
2. Pre-test
• Define blood bank?
• What are the major elements of blood?
• How to preserve blood for longer time?
• What are the main functions of blood?
• Is blood transfusion dangerous for
donor or recipient?
• Who is need a blood transfusion?
3. Objectives
3
• A student after completion this lecture, will be able to:
1. Define “blood bank”
2. Write short notes about history of transfusion practice.
3. Know how to preserve blood
4. Enumerate blood products
5. Define apheresis
6. Define RBC lesion
7. Write detailed notes about blood storage.
4. Definitions
• Blood bank: is a cache or bank of blood
or blood components, gathered as a
result of blood donation, stored and
preserved for later use in blood
transfusions.
• The term "blood bank" typically refers to a
division of a hospital where the storage of
blood product occurs and where proper
testing is performed (to reduce the risk of
transfusion related adverse events).
4
5. Definitions
• Blood donor: is a person who donates (gives) blood
voluntarily.
• Blood recipient: is a patient who receipt (receives) blood,
for therapeutic purposes.
• Aim of understanding or teaching blood transfusion is to get
a full information about what occurs due to transfusion and
donation of blood, along with the acquired diseases, which
might transmitted from donors to recipients.
5
6. HISTORY
• An early development leading to the
establishment of blood banks occurred in
1915, when Richard Lewison of Mount Sinai
Hospital in New York City initiated the use of
sodium citrate as an anticoagulant.
• This discovery transformed the blood
transfusion procedure from direct (vein-to-vein)
to indirect.
• In the same year, Richard Weil demonstrated
the feasibility of refrigerated storage of
anticoagulated blood.
6
7. HISTORY
• The introduction of a citrate-glucose solution by Francis
Peyton Rous and JR Turner two years later permitted
storage of blood in containers for several days, thus
opening the way for the first "blood depot" established in
Britain during World War I.
• Oswald Hope Robertson, a medical researcher and U.S.
Army officer who established the depots, is now recognized
as the creator of the first blood bank.
7
8. HISTORY
• By the mid-1930s, the Soviet Union had set up a system of at
least sixty large blood centers and more than 500 subsidiary
ones, all storing "canned" blood and shipping it to all corners of
the country.
• News of the Soviet experience traveled to America, where in
1937 Bernard Fantus, director of therapeutics at the Cook County
Hospital in Chicago, established the first hospital blood bank in
the United States.
• In creating a hospital laboratory that preserved and stored donor
blood, Fantus originated the term "blood bank". 8
9. HISTORY
• Within a few years, hospital and community blood banks
were established across the United States.
• Willem Johan Kolff organized the first blood bank in Europe
(in 1940).
• An important breakthrough came in 1939-40 when Karl
Landsteiner, Alex Wiener, Philip Levine, and R.E. Stetson
discovered the Rh blood group system, which was found to
be the cause of the majority of transfusion reactions up to
that time.
9
10. HISTORY
• Three years later, the introduction by J.F. Loutit and Patrick L.
Mollison of acid-citrate-dextrose (ACD) solution, which reduces
the volume of anticoagulant, permitted transfusions of greater
volumes of blood and allowed longer term storage.
• Carl Walter and W.P. Murphy, Jr., introduced the plastic bag for
blood collection in 1950.
10
11. HISTORY
• Replacing breakable glass bottles with durable
plastic bags allowed for the evolution of a
collection system capable of safe and easy
preparation of multiple blood components from a
single unit of Whole Blood.
• An anticoagulant preservative, CPDA-1 was
introduced in 1979. It decreased wastage from
expiration and facilitated resource sharing among
blood banks. Newer solutions contain adenine
and extend the shelf life of red cells to 42 days.
11
CPDA-1
Citrate
Phosphate
Dextrose
Adenine
12. COLLECTION AND PROCESSING
• In the U.S., certain standards are set for the collection and
processing of each blood product.
• "Whole blood" (WB) is the proper name for one defined product,
specifically unseparated venous blood with an approved
preservative added.
• Most blood for transfusion is collected as whole blood.
• Autologous donations are sometimes transfused without further
modification, however whole blood is typically separated (via
centrifugation) into its components, with red blood cells (RBC) in
solution being the most commonly used product.
12
13. COLLECTION AND PROCESSING
• Units of WB and RBC are both kept refrigerated at 33.8
to 42.8 °F (1.0 to 6.0 °C), with maximum permitted storage
periods (shelf lives) of 35 and 42 days respectively.
• RBC units can also be frozen when buffered with glycerol,
but this is an expensive and time-consuming process, and
is rarely done.
• Frozen red cells are given an expiration date of up to ten
years and are stored at -85 °F (-65 °C).
13
14. COLLECTION AND PROCESSING
• Blood plasma made into a variety of frozen components, and is
labeled differently based on when it was frozen and what the
intended use of the product is.
• If the plasma frozen promptly and is intended for transfusion, it is
typically labeled as fresh frozen plasma (FFP).
• If it is intended to be made into other products, it is typically
labeled as recovered plasma or plasma for fractionation.
• Cryoprecipitate can be made from other plasma components,
these components must be stored at 0 ºF (-18 ºC).
14
15. COLLECTION AND PROCESSING
• Buffy coat: is the layer between
the red cells and the plasma, which
is some time removed to make
platelets for transfusion.
• Platelets are typically pooled
before transfusion and have a shelf
life of 5 to 7 days, stored at room
temperature (72 ºF or 22 ºC).
15
16.
17. COLLECTION AND PROCESSING
• Some blood banks also collect products by apheresis (is a
medical technology in which the blood of a donor is passed
through an apparatus that separates out one particular
constituent and returns the remainder to the circulation).
• The most common components collected is plasma via
plasmapheresis, red blood cells and platelets can be
collected by similar methods.
• These products generally have the same shelf life and
storage conditions as their conventionally-produced
counterparts. 16
18. STORAGE AND MANAGEMENT
• Routine blood storage is 42 days or 6 weeks for stored
packed red blood cells (also called "StRBC" or "pRBC"), by
far the most commonly transfused blood product, and
involves refrigeration but usually not freezing.
• There has been increasing controversy about whether a
given product unit's age is a factor in transfusion efficacy,
specifically on whether "older" blood directly or indirectly
increases risks of complications.
17
19. STORAGE AND MANAGEMENT
• Studies have not been consistent on answering this question,
with some showing that older blood is indeed less effective but
with others showing no such difference; nevertheless, as storage
time remains the only available way to estimate quality status or
loss, a first-in-first-out inventory management approach is
standard presently.
• It is also important to consider that there is large variability in
storage results for different donors, which combined with limited
available quality testing, poses challenges to clinicians and
regulators seeking reliable indicators of quality for blood products
and storage systems. 18
20. STORAGE AND MANAGEMENT
• Transfusions of platelets are comparatively far less
numerous, but they present unique storage/management
issues. Platelets may only be stored for 7 days, due largely
to their greater potential for contamination, which is in turn
due largely to a higher storage temperature.
19
21. RBC STORAGE LESION
• Insufficient transfusion efficacy can result from red blood cell
(RBC) blood product units damaged by so-called storage lesion
[a set of biochemical and biomechanical changes which occur
during storage].
• With red cells, this can decrease viability and ability for tissue
oxygenation.
• Although some of the biochemical changes are reversible after
the blood is transfused, the biomechanical changes are less so,
and rejuvenation products are not yet able to adequately reverse
this phenomenon. 20
22. RBC STORAGE LESION
• Current regulatory measures are in place to minimize RBC
storage lesion-including a maximum shelf life (currently 42 days),
a maximum auto-hemolysis threshold (currently 1% in the US),
and a minimum level of post-transfusion RBC survival in vivo
(currently 75% after 24 hours).
• Many physicians have adopted a so-called "restrictive protocol"-
whereby transfusion is held to a minimum-due in part to the noted
uncertainties surrounding storage lesion, in addition to the very
high direct and indirect costs of transfusions, along with the
increasing view that many transfusions are inappropriate or use
too many RBC units. 21
23. LONG TERM STORAGE
• "Long-term" storage for all blood products is relatively
uncommon, compared to routine/short-term storage.
• Cryopreservation of red blood cells is done to store rare
units for up to ten years.
• The cells are incubated in a glycerol solution which acts as
a cryoprotectant ("antifreeze") within the cells. The units are
then placed in special sterile containers in a freezer at very
low temperatures.
22